Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Cramp Daniella
   2. Issuer Name and Ticker or Trading Symbol
ALERE INC. [ALR] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Global Pres., Cardiometabolic
(Last)
(First)
(Middle)
51 SAWYER ROAD, SUITE 200		 3. Date of Earliest Transaction (Month/Day/Year)
10/03/2017
(Street)

WALTHAM, MA 02453		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/03/2017   D   28,298 D (1) 0 D  
Common Stock 10/03/2017   D   275 D (1) 0 I See footnote (4)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $ 19.15 10/03/2017   D     10,000   (2)   (2) Common Stock 10,000 (2) 0 D  
Employee Stock Option (Right to Buy) $ 18.91 10/03/2017   D     2,500   (2)   (2) Common Stock 2,500 (2) 0 D  
Employee Stock Option (Right to Buy) $ 35.58 10/03/2017   D     14,709   (2)   (2) Common Stock 14,709 (2) 0 D  
Employee Stock Option (Right to Buy) $ 38.64 10/03/2017   D     5,000   (2)   (2) Common Stock 5,000 (2) 0 D  
Employee Stock Option (Right to Buy) $ 26.06 10/03/2017   D     40,000   (2)   (2) Common Stock 40,000 (2) 0 D  
Employee Stock Option (Right to Buy) $ 19.2 10/03/2017   D     50,000   (2)   (2) Common Stock 50,000 (2) 0 D  
Employee Stock Option (Right to Buy) $ 33.73 10/03/2017   D     25,000   (2)   (2) Common Stock 25,000 (2) 0 D  
Employee Stock Option (Right to Buy) $ 45.47 10/03/2017   D     45,000   (2)   (2) Common Stock 45,000 (2) 0 D  
Employee Stock Option (Right to Buy) $ 38.01 10/03/2017   D     15,000   (2)   (2) Common Stock 15,000 (2) 0 D  
Employee Stock Option (Right to Buy) $ 25.43 10/03/2017   D     1,500   (2)   (2) Common Stock 1,500 (2) 0 D  
Employee Stock Option (Right to Buy) $ 25.68 10/03/2017   D     15,000   (2)   (2) Common Stock 15,000 (2) 0 D  
Employee Stock Option (Right to Buy) $ 36.74 10/03/2017   D     5,000   (2)   (2) Common Stock 5,000 (2) 0 D  
Restricted Stock Units (3) 10/03/2017   D     19,470   (3)   (3) Common Stock 19,470 (3) 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Cramp Daniella
51 SAWYER ROAD
SUITE 200
WALTHAM, MA 02453		       Global Pres., Cardiometabolic  

Signatures

 /s/ Doug Barry, Attorney-in-Fact   10/03/2017
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration").
(2) Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option.
(3) Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration.
(4) These securities are owned by the Cramp Family Trust for which the reporting person and her spouse are the trustees.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.